Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Stopping minoxidil and draining fluid around the heart can save lives in rare cases.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Baricitinib is effective as a treatment for severe hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The combination therapy improved severe alopecia areata in a patient after 14 days.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Topical ruxolitinib quickly improves non-segmental vitiligo.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Clofazimine effectively treated ashy dermatosis in a patient.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.